Jsonify | I want to get continuous structured data on emerging clinical best practices, evidence-based guidelines, and value-based care model outcomes from medical journals, academic research portals, and competitor health system innovation sites.

I want to get continuous structured data on emerging clinical best practices, evidence-based guidelines, and value-based care model outcomes from medical journals, academic research portals, and competitor health system innovation sites.

Click to explore each section This is a real demo! Click to explore each section.

Pilot Configuration

Goal I want to get continuous structured data on emergi... Access continuous insights on clinical best practices and outcomes — effortlessly automated from the latest research and innovation.

12 website or app sources The Jsonify AI will open these automatically to explore and find your information

pubmed.ncbi.nlm.nih.gov

clinicaltrials.gov

jamanetwork.com

thelancet.com +8 more

10 data columns

12 dashboard widgets

3 integrations

1 notification

Recommended

Pilot Phase (Scoped Evaluation)

Up to 12 weeks

€3,000 / month

Typical scope: multi-country, weekly updates, multiple categories

Real data from real sources
Live dashboards or export feeds
Validate scope, refresh cadence, quality
Fixed price, no ongoing commitment

Most teams start here to validate fit before expanding.

Post-pilot: Production pricing depends on scope. Use estimator to see typical monthly range →

Now, schedule a short call below to confirm scope and start the pilot, or build something new.

or email us at paul@jsonify.co

Data sources are the websites and apps where information will be collected from. These can be changed or expanded at any time. This is turned into data rows.

pubmed.ncbi.nlm.nih.gov

clinicaltrials.gov

jamanetwork.com

thelancet.com

healthaffairs.org

nccn.org

cancer.gov

ahrq.gov

healthit.gov

sciencedirect.com

bmj.com

researchgate.net

Add Source

Sample data preview. This is synthetic test data generated to illustrate the structure. Real data from your sources will be populated during the pilot. This data powers the dashboard widgets.

	id	Source	Title	StudyType	Population	PrimaryOutcome	EffectSize	CostEstimate	Status	LastUpdated
	1	pubmed.ncbi.nlm.nih.gov	Implementation of outpatient antibiotic stewardship reduces inappropriate prescriptions in primary care: cluster-randomized trial ... show all	Cluster-randomized trial	Primary care clinics; adults and children (n=8,420 encounters)	Proportion of inappropriate antibiotic prescriptions within 30 days	Relative reduction 28% (95% CI 22–34)	$12,400 per clinic implementation (USD)	Published	Feb 2, 2026
	2	clinicaltrials.gov	Telehealth cardiac rehab vs center-based: randomized noninferiority trial	Randomized controlled trial	Post-MI patients (n=620), mean age 61	6-minute walk distance at 12 weeks	Noninferior; mean difference -8m (95% CI -14 to -2)	Estimated program cost $1,150 per patient (USD)	Active, Completed	Feb 3, 2026
	3	jamanetwork.com	Value-based bundled payments for hip fracture reduce LOS without increased readmissions	Observational cohort	Older adults with hip fracture (n=3,200)	Length of stay and 30-day readmission rate	LOS reduced by 1.6 days; readmission unchanged (RR 1.03)	Average savings $3,200 per admission (USD)	Published	Feb 1, 2026
	4	thelancet.com	Early dexamethasone and steroid-sparing outcome in severe pneumonia: multi-center RCT	Multi-center randomized controlled trial	Adults with severe community-acquired pneumonia (n=1,450)	30-day mortality	Absolute risk reduction 3.2% (95% CI 1.1–5.3)	Incremental drug cost $18 per patient (USD)	Published	Feb 2, 2026
	5	healthaffairs.org	Accountable care organizations with social needs navigation lower total cost for high-risk patients	Quasi-experimental difference-in-differences	High-risk Medicare beneficiaries (n=12,100)	Annual per-beneficiary total cost	$1,150 savings per beneficiary/year (95% CI $600–$1,700)	Program cost $420 per beneficiary/year (USD)	Published	Feb 3, 2026
	6	nccn.org	Tumor genomic-guided therapy improves progression-free survival in metastatic colorectal cancer	Prospective cohort	Metastatic CRC patients receiving NGS-guided therapy (n=480)	Progression-free survival	Median PFS 9.8 vs 6.1 months (HR 0.68)	NGS panel cost $2,900 per patient (USD)	Published guideline update	Feb 4, 2026
	7	cancer.gov	Low-dose CT screening outreach increases lung cancer stage I detection in rural populations	Program evaluation	Rural eligible smokers (n=9,760 invited)	Proportion diagnosed at stage I	Stage I detection increased from 18% to 33% (RR 1.83)	Outreach cost $85 per screened person (USD)	Report published	Feb 3, 2026
	8	ahrq.gov	Clinical decision support reduced opioid prescribing after ED discharge: pragmatic study	Pragmatic controlled study	ED discharges with acute pain (n=15,300 encounters)	Morphine milligram equivalents prescribed per encounter	Mean MME reduced by 22% (95% CI 19–25)	CDS implementation $7,600 per facility (USD)	Published	Feb 2, 2026
	9	healthit.gov	FHIR-based interoperability pilot improves medication reconciliation accuracy	Pilot implementation study	Two-hospital health system; adult inpatients (n=4,200)	Medication discrepancies per patient at discharge	Discrepancies reduced by 1.9 per patient (p<0.001)	Pilot build cost $145,000 (USD)	Completed pilot	Feb 4, 2026
	10	sciencedirect.com	Home-based palliative care reduces emergency visits among advanced heart failure patients	Matched cohort study	Advanced HF patients (n=1,240 matched pairs)	ED visits per patient-year	ED visits reduced by 37% (IRR 0.63)	Program cost $3,800 per patient/year (USD)	Published	Feb 1, 2026
	11	bmj.com	Point-of-care CRP testing in primary care reduces antibiotic prescribing for respiratory infections	Randomized controlled trial	Adults with acute respiratory symptoms (n=2,900)	Antibiotic prescription rate within 7 days	Absolute reduction 16% (95% CI 12–20)	POC test cost $6 per test; incremental cost $48 per reduction in prescription (USD)	Published	Feb 3, 2026
	12	researchgate.net	Integrated mental health stepped-care lowers PHQ-9 scores in community clinics	Stepped-wedge trial	Primary care patients with depression (n=2,120)	Change in PHQ-9 at 12 weeks	Mean reduction 4.1 points vs 2.6 in control (mean difference 1.5)	Per-patient program cost $220 (USD)	Preprint poster	Feb 2, 2026
	13	pubmed.ncbi.nlm.nih.gov	Short-course vs standard-duration antibiotic therapy for uncomplicated pyelonephritis	Randomized noninferiority trial	Women 18–65 with uncomplicated pyelonephritis (n=1,100)	Clinical cure at day 14	Short-course noninferior; difference -0.8% (95% CI -3.6–1.9)	Medication cost reduction $34 per patient (USD)	Published	Feb 3, 2026
	14	clinicaltrials.gov	AI triage tool to prioritize stroke alerts in EDs: multicenter validation	Prospective validation study	ED stroke code activations (n=4,800)	Sensitivity for LVO detection	Sensitivity 92% (95% CI 90–94)	Estimated licensing $45,000 per hospital/year (USD)	Recruiting, interim results	Feb 4, 2026
	15	jamanetwork.com	Remote monitoring in COPD reduces exacerbation-related hospitalizations	Randomized controlled trial	Moderate–severe COPD patients (n=980)	Hospitalization rate for exacerbation at 12 months	Relative reduction 29% (95% CI 18–40)	Remote monitoring cost $650 per patient/year (USD)	Published	Feb 2, 2026
	16	thelancet.com	Single-dose HPV vaccine provides durable protection: 10-year follow-up cohort	Longitudinal cohort	Adolescent girls and young women vaccinated (n=6,500)	Incident HPV 16/18 infection	Vaccine efficacy 87% (95% CI 82–91) at 10 years	Vaccine program cost per person $42 (USD)	Published	Feb 3, 2026
	17	healthaffairs.org	Medicaid ACOs with behavioral health integration lower total cost of care	Difference-in-differences	Medicaid beneficiaries in states with ACO pilots (n=45,600)	Per-member-per-month spending	Decrease $28 PMPM (95% CI $15–$41)	Integration start-up $2.1M per state pilot (USD)	Published	Feb 1, 2026
	18	nccn.org	Adjuvant immunotherapy duration optimization in melanoma: consensus update	Guideline consensus	Resected stage III–IV melanoma patients	Recurrence-free survival recommendations	Recommended 6 months may be sufficient for low-risk subgroup; pooled HR 0.95	Estimated drug cost reduction $48,000 per patient when shortened (USD)	Guideline updated	Feb 4, 2026
	19	cancer.gov	Routine germline testing increases actionable variants detection in pancreatic cancer	Prospective registry	Patients with pancreatic adenocarcinoma (n=1,320)	Proportion with actionable germline variants	Actionable variants detected in 9.7% vs historical 4.1%	Testing cost $1,200 per patient (USD)	Report published	Feb 2, 2026
	20	ahrq.gov	Enhanced recovery pathways reduce opioid use and LOS after colorectal surgery	Systematic review and meta-analysis	Adult colorectal surgery patients across 18 studies (n≈22,400)	Opioid consumption and length of stay	Opioid use reduced 41%; LOS reduced 0.9 days (95% CI 0.6–1.2)	Per-patient implementation cost $320 (USD)	Published	Feb 3, 2026
	21	healthit.gov	User-centered EHR redesign improves clinician documentation time and satisfaction	Before-after implementation study	Primary care physicians (n=142)	Mean documentation time per patient	Time reduced by 6.4 minutes (p<0.001); satisfaction score +18%	Redesign cost $380,000 (USD)	Completed	Feb 2, 2026
	22	sciencedirect.com	SGLT2 inhibitors decrease hospitalization for heart failure in patients with CKD	Meta-analysis of RCTs	Patients with CKD stages 3–4 (n≈16,800 pooled)	HF hospitalization rate	Relative risk 0.72 (95% CI 0.65–0.80)	Annual drug cost $4,200 per patient (USD)	Published	Feb 1, 2026
	23	bmj.com	Rapid SARS-CoV-2 antigen testing in hospitals shortens isolation time without increasing transmission ... show all	Stepped-wedge cluster trial	Hospital inpatients under suspected COVID-19 isolation (n=5,600)	Median isolation duration	Isolation reduced by 28 hours; no increase in nosocomial transmission (IRR 1.02)	Testing program cost $3.10 per test (USD)	Published	Feb 4, 2026
	24	researchgate.net	Community paramedicine program reduces avoidable ED visits among frail elders	Prospective matched cohort	Homebound elders referred to community paramedics (n=760)	Avoidable ED visits at 6 months	Reduced by 44% (RR 0.56)	Program cost $1,020 per patient (USD)	Preprint	Feb 2, 2026
	25	pubmed.ncbi.nlm.nih.gov	Low-dose chemoradiation with immunotherapy shows promising pathologic complete response in esophageal cancer ... show all	Phase II single-arm trial	Locally advanced esophageal adenocarcinoma (n=86)	Pathologic complete response rate	pCR 41% (95% CI 30–52)	Estimated regimen cost $38,500 per patient (USD)	Published	Feb 3, 2026
	26	clinicaltrials.gov	Wearable glucose sensor to guide insulin dosing in type 1 diabetes: randomized crossover	Randomized crossover trial	Adults with T1D using MDI (n=210)	Time in range (70–180 mg/dL) over 12 weeks	Increase in TIR by 6.8 percentage points (95% CI 4.2–9.4)	Sensor annualized cost $1,100 per patient (USD)	Completed, results posted	Feb 4, 2026
	27	jamanetwork.com	Pharmacist-led medication reconciliation at discharge reduces 30-day readmissions	Cluster randomized trial	General medicine discharges (n=6,300 patients)	30-day readmission rate	Absolute reduction 2.1% (95% CI 1.0–3.2)	Per-hospital annual cost $92,000 (USD)	Published	Feb 1, 2026
	28	thelancet.com	Single-visit cervical cancer screening with HPV self-sampling effective in low-resource settings	Randomized pragmatic trial	Screen-eligible women in LMICs (n=11,200)	Screen-and-treat completion rate	Completion increased from 57% to 84% (RR 1.47)	Per-woman program cost $9.50 (USD)	Published	Feb 2, 2026
	29	healthaffairs.org	Price-transparency tool for imaging reduces low-value MRI ordering	Interrupted time series	Primary care clinicians ordering imaging (n=2,400 clinicians)	Rate of low-value MRI orders per 1,000 visits	Reduced by 12% (95% CI 7–17)	Tool development $58,000; estimated annual maintenance $9,600 (USD)	Published	Feb 3, 2026
Looking for more? Great news − this is just a small sample. Jsonify production workflows process anywhere from tens of thousands to millions of real data rows per run!

–

Recent studies show a 25% increase in adherence to evidence-based guidelines in oncology treatments since 2025.

Research indicates a significant correlation between value-based care models and improved patient outcomes, particularly in chronic disease management.

Emerging best practices emphasize interdisciplinary collaboration, which has been linked to a 15% reduction in hospital readmission rates.

Title	Authors	Journal	Publication Date	Summary
Impact of Telemedicine on Healthcare Delivery	Smith J., Doe A.	JAMA Network	2026-01-15	Explores how telemedicine improves access to care and patient outcomes.
Guidelines for Management of Chronic Pain	Johnson R., Lee K.	The Lancet	2026-01-20	Presents evidence-based strategies for chronic pain management in diverse populations.
Value-Based Care Models in Oncology	Brown T., Garcia M.	Health Affairs	2026-01-25	Analyzes outcomes of value-based care models in cancer treatment.
Emerging Trends in Preventive Healthcare	White P., Kim J.	BMJ	2026-01-30	Discusses innovative preventive healthcare practices and their effectiveness.
Clinical Trials on Novel Therapies for Diabetes	Chen L., Patel N.	ClinicalTrials.gov	2026-02-01	Reviews recent clinical trials targeting new diabetes therapies and their results.

Recent studies published in JAMA and The Lancet show a significant shift towards telehealth integration in patient care models across leading health systems.

Emerging evidence-based guidelines from NCCN highlight the effectiveness of personalized treatment plans in oncology, which are being adopted by competitors.

Health Affairs reports a 25% increase in patient satisfaction scores related to value-based care models implemented by major health systems in the past year.

Clinical trials.gov indicates a growing number of trials focusing on AI applications in healthcare, suggesting a trend towards technology-driven patient outcomes.

Research from BMJ underscores the importance of interdisciplinary collaboration in improving clinical outcomes, which is being actively pursued by competitor systems.

Trial Name	Phase	Condition	Start Date	Source
A Study of Drug A in Patients with Condition X	Phase 2	Condition X	2025-06-15	clinicaltrials.gov
Effectiveness of Treatment B on Condition Y	Phase 3	Condition Y	2026-01-10	jamanetwork.com
Long-term Outcomes of Procedure C for Condition Z	Phase 1	Condition Z	2025-12-01	thelancet.com
Comparative Study of Device D vs. Standard Care	Phase 2	Condition W	2025-08-20	healthaffairs.org
Evaluation of Protocol E in Cancer Patients	Phase 3	Cancer	2026-02-01	nccn.org
Innovative Approach to Treat Condition V	Phase 1	Condition V	2025-11-15	cancer.gov
Impact of Intervention F on Patient Outcomes	Phase 2	Condition U	2026-01-25	sciencedirect.com